Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

27. Februar 2018 14:20 ET | Quelle: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals Releases Annual Report for 2017

Company Release no. 2/2018 To: NASDAQ Copenhagen...
14. Februar 2018 15:36 ET | Quelle: Veloxis Pharmaceuticals A/S

Veloxis Secures USD 60M in Debt Financing

Company Release no. 01/2018 To: NASDAQ Copenhagen A/S ...
31. Dezember 2017 12:00 ET | Quelle: Veloxis Pharmaceuticals A/S

Veloxis Announces the Total Number of Shares and Voting Rights in the Company as of 31 December 2017

Company Release no. 27/2017 To: NASDAQ Copenhagen...
29. Dezember 2017 12:13 ET | Quelle: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals Announces Financial Calendar for 2018

Company Release no. 26/2017 To: NASDAQ Copenhagen...
22. Dezember 2017 12:17 ET | Quelle: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program

Company Release no. 25/2017 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 22 December...
01. Dezember 2017 00:00 ET | Quelle: Veloxis Pharmaceuticals A/S

Veloxis Increases Share Capital in Connection with Exercise of Warrants

Company Release no. 24/2017 To: NASDAQ Copenhagen A/S Copenhagen,...
14. November 2017 11:23 ET | Quelle: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals Announces Financial Results for the First Nine Months of 2017

Highlights Record product revenue of tUSD 5,924 achieved in Q3 2017. Revenue reached tUSD 22,092 in the first nine months of 2017 representing an increase of 301% compared to the same...
31. Oktober 2017 18:47 ET | Quelle: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program

Company Release no. 22/2017 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 31...
30. September 2017 06:00 ET | Quelle: Veloxis Pharmaceuticals A/S

Veloxis Announces the Total Number of Shares and Voting Rights in the Company as of 30 September 2017

Company Release no. 21/2017 To: NASDAQ Copenhagen A/S Copenhagen,...
20. September 2017 17:03 ET | Quelle: Veloxis Pharmaceuticals A/S

Alastair McEwan Steps Down as Chief Operating Officer of Veloxis Pharmaceuticals A/S

Company Release no. 20/2017 To: NASDAQ Copenhagen A/S ...

Vorherige Seite

Nächste Seite